Bioanalytical procedures for determination of drugs of abuse in blood

@article{Kraemer2007BioanalyticalPF,
  title={Bioanalytical procedures for determination of drugs of abuse in blood},
  author={T. Kraemer and L. D. Paul},
  journal={Analytical and Bioanalytical Chemistry},
  year={2007},
  volume={388},
  pages={1415-1435}
}
  • T. Kraemer, L. D. Paul
  • Published 2007
  • Chemistry, Medicine
  • Analytical and Bioanalytical Chemistry
    • Determination of drugs of abuse in blood is of great importance in clinical and forensic toxicology. This review describes procedures for detection of the following drugs of abuse and their metabolites in whole blood, plasma or serum: Δ9-tetrahydrocannabinol, 11-hydroxy-Δ9-tetrahydrocannabinol, 11-nor-9-carboxy-Δ9-tetrahydrocannabinol, 11-nor-9-carboxy-Δ9-tetrahydrocannabinol glucuronide, heroin, 6-monoacetylmorphine, morphine, morphine-6-glucuronide, morphine-3-glucuronide, codeine… CONTINUE READING
    View on Springer
    ncbi.nlm.nih.gov
    96 Citations
    Highly Influential Citations
    1
    Background Citations
    13
    Methods Citations
    9
    96 Citations
    Citation Type

    Citation Type

    Economical Synthesis of 13C-Labeled Opiates, Cocaine Derivatives and Selected Urinary Metabolites by Derivatization of the Natural Products
    • 4
    • PDF
    Quantification of drugs of abuse in municipal wastewater via SPE and direct injection liquid chromatography mass spectrometry
    • 47
    Determination of 19 drugs of abuse and metabolites in whole blood by high-performance liquid chromatography–tandem mass spectrometry
    • 80
    Determination of cocaine, metabolites and a crack cocaine biomarker in whole blood by liquid-liquid extraction and UHPLC-MS/MS.
    • 9
    Drug screening of whole blood by ultra-performance liquid chromatography-tandem mass spectrometry.
    • 102
    • PDF
    Paper spray and extraction spray mass spectrometry for the direct and simultaneous quantification of eight drugs of abuse in whole blood.
    • 123
    A one-step extraction procedure for the screening of cocaine, amphetamines and cannabinoids in postmortem blood samples.
    • 17
    • PDF
    Simultaneous determination of cocaine/crack and its metabolites in oral fluid, urine and plasma by liquid chromatography-mass spectrometry and its application in drug users.
    • 14
    A novel immunoassay for quantitative drug abuse screening in serum.
    • 6
    Micro-solid phase extraction coupled with high-performance liquid chromatography-tandem mass spectrometry for the determination of stimulants, hallucinogens, ketamine and phencyclidine in oral fluids.
    • 48

    References

    SHOWING 1-10 OF 109 REFERENCES
    Concentration profiles of cocaine, pyrolytic methyl ecgonidine and thirteen metabolites in human blood and urine: determination by gas chromatography-mass spectrometry.
    • 54
    Advances in analytical toxicology: the current role of liquid chromatography–mass spectrometry in drug quantification in blood and oral fluid
    • H. Maurer
    • Medicine, Chemistry
    • Analytical and bioanalytical chemistry
    • 2005
    • 128
    Enantioselective quantitation of the ecstasy compound (R)- and (S)-N-ethyl-3,4-methylenedioxyamphetamine and its major metabolites in human plasma and urine.
    • J. Buechler, M. Schwab, +6 authors K. A. Kovar
    • Chemistry, Medicine
    • Journal of chromatography. B, Analytical technologies in the biomedical and life sciences
    • 2003
    • 29
    The quantitative analysis of heroin, methadone and their metabolites and the simultaneous detection of cocaine, acetylcodeine and their metabolites in human plasma by high-performance liquid chromatography coupled with tandem mass spectrometry.
    • 121
    Toxicokinetics of Amphetamines: Metabolism and Toxicokinetic Data of Designer Drugs, Amphetamine, Methamphetamine, and Their N-Alkyl Derivatives
    • 206
    Screening for and validated quantification of amphetamines and of amphetamine- and piperazine-derived designer drugs in human blood plasma by gas chromatography/mass spectrometry.
    • 158
    Drugs of Abuse Monitoring in Blood for Control of Driving Under the Influence of Drugs
    • 99
    • PDF
    Stereochemical analysis of 3,4-methylenedioxymethamphetamine and its main metabolites in human samples including the catechol-type metabolite (3,4-dihydroxymethamphetamine).
    • 76
    • PDF
    Determination of drugs of abuse and their metabolites in human plasma by liquid chromatography-mass spectrometry. An application to 156 road fatalities.
    • 54
    Stereochemical analysis of 3,4-methylenedioxymethamphetamine and its main metabolites by gas chromatography/mass spectrometry.
    • 41